SCG Cell Therapy
PrivateLast Round
Series C
Extension
Apr 5, 2023
Est. Valuation
$210M
Total Funding Raised
$26.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SCG Cell Therapy operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series C Extension round in April 2023.
SCG Cell Therapy is a biotechnology company that develops novel immunotherapies for patients with infections and associated cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SCG Cell Therapy Comparables
Compare SCG Cell Therapy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lion TCR | 88% | |
| Beijing CorreGene Biotechnology Co., Ltd. | 84% | |
| TCRCure Biopharma | 83% |
For institutional investors. Book with your work email.
SCG Cell Therapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Apr 5, 2023 | ||||
| Series C | Jun 22, 2021 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 212% MoM.
- Oct 18, 2025
Will present at the ESMO 2025 conference.
For institutional investors. Book with your work email.
SCG Cell Therapy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SCG Cell Therapy's valuation, stock price, and market status.
Is SCG Cell Therapy a public or private company?
SCG Cell Therapy is a private company.
What is the current stock price of SCG Cell Therapy?
SCG Cell Therapy is a private company, so its shares have no public market price. Caplight tracks SCG Cell Therapy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SCG Cell Therapy worth (valuation)?
SCG Cell Therapy's valuation is estimated at $210.0M based on funding round data.
Can I buy SCG Cell Therapy stock?
SCG Cell Therapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SCG Cell Therapy's last funding round?
SCG Cell Therapy's most recent funding round was Series C Extension on April 5, 2023.
Who are the main investors in SCG Cell Therapy?
Investor information for SCG Cell Therapy is not publicly disclosed.
Will SCG Cell Therapy IPO soon?
No public IPO plans have been announced for SCG Cell Therapy.
How can I track SCG Cell Therapy secondary market activity?
Caplight tracks bids, offers, and trades in SCG Cell Therapy's shares on secondary markets.